VRSE.F Stock Overview
Verisante Technology Inc. does not have significant operations.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 2 more risks
Verisante Technology Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.005 |
| 52 Week High | US$0.01 |
| 52 Week Low | US$0.00001 |
| Beta | 246.38 |
| 1 Month Change | -50.00% |
| 3 Month Change | -42.53% |
| 1 Year Change | -19.35% |
| 3 Year Change | -93.75% |
| 5 Year Change | 400.00% |
| Change since IPO | -99.94% |
Recent News & Updates
Recent updates
Shareholder Returns
| VRSE.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | -4.1% | -3.7% |
| 1Y | -19.4% | -2.2% | 20.5% |
Return vs Industry: VRSE.F underperformed the US Medical Equipment industry which returned 2.2% over the past year.
Return vs Market: VRSE.F underperformed the US Market which returned 20.2% over the past year.
Price Volatility
| VRSE.F volatility | |
|---|---|
| VRSE.F Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: VRSE.F's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine VRSE.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | n/a | Thomas Braun | www.verisante.com |
Verisante Technology Inc. does not have significant operations. Previously, it was involved in the design and manufacture of innovative cancer diagnostic devices. The company was formerly known as T-Ray Science Inc. and changed its name to Verisante Technology Inc. in January 2011.
Verisante Technology Inc. Fundamentals Summary
| VRSE.F fundamental statistics | |
|---|---|
| Market cap | US$219.69k |
| Earnings (TTM) | -US$65.57k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-3.4x
P/E RatioIs VRSE.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VRSE.F income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$90.53k |
| Earnings | -CA$90.52k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0021 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did VRSE.F perform over the long term?
See historical performance and comparison